SCHEMBL16229757

SCHEMBL16229757

CN1C2C1C21Cc2cc(F)c(OCCNS(=O)(=O)c3cnn(C)c3)cc2C1Cc1cccc(Cl)c1

nearest known ligand 0.43

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 6/20 0.43
HTR1A P08908 6/20 0.34
HTR7 P34969 6/20 0.34
DRD2 P14416 2/20 0.34
HTR6 P50406 2/20 0.34
ADRA1A P35348 2/20 0.34
ADRA1B P35368 2/20 0.34
TP53 P04637 1/20 0.32
CHRM2 P08172 1/20 0.32
CHRM1 P11229 1/20 0.32
RRM1 P23921 1/20 0.32
RRM2B Q7LG56 1/20 0.32
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16229753 0.93 SLC6A9 (0.41) SLC6A9HTR1AHTR7DRD2HTR6
SCHEMBL16784640 0.92 SLC6A9 (0.41) SLC6A9HTR1AHTR7DRD2HTR6
SCHEMBL16784648 0.90 SLC6A9 (0.42) SLC6A9HTR1AHTR7DRD2HTR6
SCHEMBL16229761 0.88 SLC6A9 (0.37) SLC6A9HTR6TP53CHRM2CHRM1
SCHEMBL16784630 0.88 SLC6A9 (0.54) SLC6A9HTR1AHTR7
SCHEMBL16229770 0.88 SLC6A9 (0.53) SLC6A9
SCHEMBL16229766 0.87 TP53 (0.35) SLC6A9TP53CHRM2CHRM1RRM1
SCHEMBL16229805 0.85 SLC6A9 (0.38) SLC6A9HTR1AHTR7DRD2HTR6
SCHEMBL16229765 0.85 SLC6A9 (0.38) SLC6A9HTR1AHTR7DRD2HTR6
SCHEMBL16229783 0.84 SLC6A9 (0.41) SLC6A9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9051280-B2 Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Deutschland GmbH & Co. KG (DE) 2015-06-09 US disclosed
US-8883839-B2 Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy ABBOTT LABORATORIES (US) 2014-11-11 US disclosed